Literature DB >> 30760471

Prevotella copri in individuals at risk for rheumatoid arthritis.

Axel Finckh1, Till Strowig2,3, Deshire Alpizar-Rodriguez4, Till Robin Lesker5, Achim Gronow5, Benoît Gilbert4, Elena Raemy4, Celine Lamacchia4, Cem Gabay4.   

Abstract

OBJECTIVES: Rheumatoid arthritis (RA) has been associated with a relative expansion of faecal Prevotellaceae. To determine the microbiome composition and prevalence of Prevotella spp. in a group of individuals at increased risk for RA, but prior to the development of the disease.
METHODS: In an ongoing cohort study of first-degree relatives (FDRs) of patients with RA, we identified 'FDR controls', asymptomatic and without autoantibodies, and individuals in pre-clinical RA stages, who had either developed anticitrullinated peptide antibodies or rheumatoid factor positivity and/or symptoms and signs associated with possible RA. Stool sampling and culture-independent microbiota analyses were performed followed by descriptive statistics and statistical analyses of community structures.
RESULTS: A total of 133 participants were included, of which 50 were categorised as 'FDR controls' and 83 in 'pre-clinical RA stages'. The microbiota of individuals in 'pre-clinical RA stages' was significantly altered compared with FDR controls. We found a significant enrichment of the bacterial family Prevotellaceae, particularly Prevotella spp., in the 'pre-clinical RA' group (p=0.04).
CONCLUSIONS: Prevotella spp. enrichment in individuals in pre-clinical stages of RA, before the onset of RA, suggests a role of intestinal dysbiosis in the development of RA. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology of ra; microbiome; pre-clinical stages of ra; rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 30760471     DOI: 10.1136/annrheumdis-2018-214514

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  86 in total

Review 1.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

Review 2.  Prevotella diversity, niches and interactions with the human host.

Authors:  Adrian Tett; Edoardo Pasolli; Giulia Masetti; Danilo Ercolini; Nicola Segata
Journal:  Nat Rev Microbiol       Date:  2021-05-28       Impact factor: 60.633

Review 3.  Microbiota-mediated mucosal inflammation in arthritis.

Authors:  Meagan E Chriswell; Kristine A Kuhn
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-03-06       Impact factor: 4.098

Review 4.  Microbial Influences of Mucosal Immunity in Rheumatoid Arthritis.

Authors:  Timothy M Wilson; Brandon Trent; Kristine A Kuhn; M Kristen Demoruelle
Journal:  Curr Rheumatol Rep       Date:  2020-10-06       Impact factor: 4.592

Review 5.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

Review 6.  On Research Progress of Western and Chinese Medicine Treatment on Pre-Rheumatoid Arthritis.

Authors:  Xiang-Yu Kong; Cheng-Ping Wen
Journal:  Chin J Integr Med       Date:  2019-10-24       Impact factor: 1.978

7.  Individuals at risk for rheumatoid arthritis harbor differential intestinal bacteriophage communities with distinct metabolic potential.

Authors:  Mihnea R Mangalea; David Paez-Espino; Kristopher Kieft; Anushila Chatterjee; Meagan E Chriswell; Jennifer A Seifert; Marie L Feser; M Kristen Demoruelle; Alexandra Sakatos; Karthik Anantharaman; Kevin D Deane; Kristine A Kuhn; V Michael Holers; Breck A Duerkop
Journal:  Cell Host Microbe       Date:  2021-05-05       Impact factor: 21.023

Review 8.  Why remission is not enough: underlying disease mechanisms in RA that prevent cure.

Authors:  Georg Schett; Yoshiya Tanaka; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2020-12-10       Impact factor: 20.543

9.  ZFP90 drives the initiation of colitis-associated colorectal cancer via a microbiota-dependent strategy.

Authors:  Ji-Xuan Han; Zhi-Hang Tao; Yun Qian; Chen-Yang Yu; Jialu Li; Zi-Ran Kang; Shiyuan Lu; Yuanhong Xie; Jie Hong; Haoyan Chen; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 10.  Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus.

Authors:  Alok K Paul; Anita Paul; Rownak Jahan; Khoshnur Jannat; Tohmina A Bondhon; Anamul Hasan; Veeranoot Nissapatorn; Maria L Pereira; Polrat Wilairatana; Mohammed Rahmatullah
Journal:  Microorganisms       Date:  2021-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.